Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-blind, Investigator-initiated, Randomized, Controlled Trial to Assess the Safety and Efficacy of Intravenous Corticosteroid Therapy to Treat Patients With Acute Myocarditis With Mildly Reduced Left Ventricular Ejection Fraction

NCT05974462 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT05974462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05974462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-blind, Investigator-initiated, Randomized, Controlled Trial to Assess the Safety and Efficacy of Intravenous Corticosteroid Therapy to Treat Patients With Acute Myocarditis With Mildly Reduced Left Ventricular Ejection Fraction
Lead sponsor
University Hospital, Antwerp
Phase
Phase 3
Overall status
Recruiting
Start date
May 24, 2024
Completion date
October 1, 2028
Enrollment
174 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocarditis